News of the WeekBiotechnology

Singapore Firm Abandons Plans for Stem Cell Therapies

Science  20 Jul 2007:
Vol. 317, Issue 5836, pp. 305
DOI: 10.1126/science.317.5836.305

You are currently viewing the summary.

View Full Text

Summary

In a sign that hopes for quick medical benefits from stem cells are fading, ES Cell International--a company established with fanfare in Singapore 7 years ago--is halting work on human embryonic stem cell therapies.